Inogen (INGN) Cash from Operations Growth (1y) (2014 - 2026)
Inogen (INGN) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.60% |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 60.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.18% |
| Dec 31, 2025 | 68.75% |
| Sep 30, 2025 | -69.01% |
| Jun 30, 2025 | -34.97% |
| Mar 31, 2025 | -253.55% |
| Dec 31, 2024 | 4.13% |
| Sep 30, 2024 | 220.00% |
| Jun 30, 2024 | 65.98% |
| Mar 31, 2024 | 24.63% |
| Dec 31, 2023 | 79.67% |
| Sep 30, 2023 | 123.04% |
| Jun 30, 2023 | -27.14% |
| Mar 31, 2023 | 65.18% |
| Dec 31, 2022 | -338.26% |
| Sep 30, 2022 | -216.73% |
| Jun 30, 2022 | -67.97% |
| Mar 31, 2022 | -732.80% |
| Dec 31, 2021 | -59.88% |
| Sep 30, 2021 | -144.39% |
| Jun 30, 2021 | 27.63% |